FdaApplication
ANDA 213669
Identifiers
- fda_app_no: ANDA213669
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2023-11-20 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BREXPIPRAZOLE | BREXPIPRAZOLE | 3MG | TABLET;ORAL |
| BREXPIPRAZOLE | BREXPIPRAZOLE | 2MG | TABLET;ORAL |
| BREXPIPRAZOLE | BREXPIPRAZOLE | 1MG | TABLET;ORAL |
| BREXPIPRAZOLE | BREXPIPRAZOLE | 4MG | TABLET;ORAL |
| BREXPIPRAZOLE | BREXPIPRAZOLE | 0.25MG | TABLET;ORAL |
| BREXPIPRAZOLE | BREXPIPRAZOLE | 0.5MG | TABLET;ORAL |
6 products